The factor in normal sera primarily responsible for the enhancement of transfection (and transformation) of Staphylococcus aureus was identified as fibronectin. Serum samples which were depleted of fibronectin by affinity chromatography showed a marked decrease in enhancing activity. Fibronectin isolated from sera of several animal species demonstrated enhancing activity.
The uptake of exogenous DNA by Staphylococcus aureus requires, in addition to 100 mM Ca2+ (17, 18) , the presence of a competence factor. This competence factor has been identified as a virion component of a serological group B staphylococcal bacteriophage (2, 6, 20) which can be supplied by natural prophage induction of lysogenic strains or experimentally in the form of a bacteriophage lysate (19) . During an attempt to neutralize the competence factor activity with antiserum specific for the bacteriophage particle, we observed that the addition of normal (nonimmune) rabbit serum to the bacterial cells before, or during, exposure to the DNA increased the recovery of transformed cells by as much as 300% (19) . This observation was termed serum enhancement and was confirmed by Martin et al. (9) , who extended the observation to sera obtained from several other animal species.
Several proteins in normal serum have been shown to interact with the cell surface of S. aureus; the most notable of these interactions is the binding of the crystallizable fragment (Fc fragment) of the immunoglobulin G molecule to cell-bound protein A (4). The immunoglobulin G fraction isolated from normal rabbit serum does not demonstrate this enhancement effect; however, a fraction containing mainly the p-globulin fraction of normal rabbit serum does demonstrate the effect (N. E. Thompson, Ph.D. dissertation, Iowa State University, Ames, Iowa, 1979). Fibronectin (FN), a ,-globulin (13), has been shown to bind to S. aureus (7) and to DNA (21) . FN has attracted considerable attention in recent years because of its diverse binding properties and its apparent role in a variety of physiological processes (for reviews, see references 10, 12, and 14) . In this study, we investigated the ability of FN to mimic the serum enhancement effect.
Because of ease of manipulation, we have routinely used transfection, rather than transformation, to assay for uptake of DNA and serum enhancement. The mechanism of DNA uptake by S. aureus is identical for transformation and transfection (2, (17) (18) (19) . Transfections were performed with strain ISP2 (= 8325 nov-124). This strain is lysogenic for bacteriophage 411, a serological group B bacteriophage; the liberation and readsorption of the virion component during growth make ISP2 competent to take up DNA upon subsequent exposure to Ca2+ (19) . Transfections were performed essentially as previously described (19) from bacteriophage 80a (2), except that 10-ml samples of an early-log-phase culture were treated with serum or serum fractions at 37°C before the cells were centrifuged and exposed to phage 80a DNA and Ca2+.
A saturating concentration of serum was determined by treating cells with increasing concentrations of serum; saturation was found to occur at approximately 1.0% (vol/vol). Therefore, a final concentration of 2.0% was used in all assays. Exposure of the cells to normal rabbit serum resulted in almost immediate enhancement (Fig. 1A) ; enhancement could be detected up to 60 min after the initial exposure (data not shown). Therefore, cells were exposed to serum or serum fractions for 10 min before the transfection procedure continued unless otherwise specified.
FN was isolated from normal sera by affinity chromatography (3), with gelatin (Difco Laboratories, Detroit, Mich.) linked to CNBr-activated Sepharose 4B (Pharmacia Fine Chemicals, Piscataway, N.J.). Each serum sample was first adsorbed with nonligated Sepharose 4B to prevent any serum components from adhering nonspecifically to the affinity column. FN was eluted with 4 M urea contained in phosphate-buffered (0.01 M, pH 7.4) saline (0.15 M NaCl), dialyzed overnight, and concentrated by dialysis against a slurry of polyethylene glycol (20 M). The material eluted from the affinity column was subjected to polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate under reducing conditions according to the procedure of Laemmli (8) with a 7% running gel and electrophoresis for 16 h at 8 mA per gel. This material, isolated from human serum, is shown in Fig. 2a . The reduced material yielded typical multiple bands with a molecular weight of approximately 220,000 (1). To confirm that this material was indeed FN, authentic human FN and the antiserum prepared against it in goats were purchased from Calbiochem-Behring, La Jolla, Calif. In double-gel diffusion assays, the putative human FN showed a line of identity with the purchased reagents (Fig.  2b) .
Sera from rabbit, horse, and human sources were subjected to affinity chromatography, and the gelatin-binding fractions were isolated. The volumes of the treated sera and the gelatin-binding fractions were adjusted to those of the original serum samples and tested for enhancing activity in the transfection system. In all cases, the enhancing activity of the serum was greatly reduced by subjecting it to affinity chromatography (Table 1) . Moreover, the gelatin-binding fraction, eluted from the column with 4 M urea, contained considerable enhancing activity ( (Fig. 1 ) may be explained in part by the fact that it took approximately 10 min to centrifuge the sample after exposure to the FN. The relationships (Fig. 1) did not reflect this processing time.
When the enhancing activity of serum was first noted, we proposed (19) that the effect might be due to preservation of the colony-forming ability of the competent cells by the serum. While no decrease in viable cell counts was noted in the ISP2 cells used in this study, only a small proportion of the cells was actually exposed to the phage component in this naturally competent system (19) , and a decrease in viability would not be easily detected. However, in light of the DNA-binding properties of FN (21) , an alternative hypothesis is that the FN, bound to the cell surface, also binds to the exogenous DNA. This might either increase the binding of DNA to the cell surface or facilitate the interaction of the DNA molecule and the cell surface-bound bacteriophage component.
To determine whether FN increases the binding of DNA to the cell, cells were exposed to FN either before or after exposure to DNA and to Ca2". The results (Table 2) indicate that no enhancement was achieved by exposing the cells to FN after they had been exposed to both DNA and Ca2 . However, some enhancement was achieved by exposing the cells to DNA and then to FN before exposing them to Ca2 . The failure to reach maximum enhancement by this protocol might be explained by the reduced level of transfection noted when cells are exposed separately to DNA and Ca2+ (Table  2) . The to FN after exposure to DNA seems to rule out the role of FN as a ligand, linking the DNA to the cell. However, it does not rule out the possibility that the FN associates with the already cell-bound DNA, creating a configuration that is more easily taken into the cell upon exposure to Ca2 . The data presented in this paper indicate that FN isolated from the sera of several animal species can enhance the transfection of competent S. aureus cells. Normal serum also enhances the recovery of transformants of several different strains of S aureus (9j 19) . Although the direct effect of FN on the transformation of these strains was not tested in this study, it seems clear that the FN present in the serum is primarily responsible for the serum-enhancing effect, and thus the effect of FN probably is neither strain nor DNA specific.
Because of the low incidence of competent cells and the complexity of the S. aureus transfection system, the precise mechanism by which the enhancement occurs is not clear. However, the data could represent a mechanism whereby the FN either stabilizes the competent cell or facilitates the uptake of cell-bound DNA.
Proctor et al. (16) have estimated that S. aureus ATCC 25923 grown under conditions similar to those of the experiments presented in this paper contains approximately 7,500 binding sites for FN. It is possible that the binding of many molecules of FN to the cell surface by the amino-terminal end (15) results in a protective "microcapsule" that stabilizes an otherwise "leaky" competent cell.
Zardi et al. (21) have noted that DNAs from bacterial sources have considerably lower affinity for human FN than does human DNA. Thus, there seems to be a degree of phylogenetic specificity involved, perhaps resulting from interactions with contaminating DNA-associated proteins such as histones (5) . If the affinity of FN for staphylococcal DNA is low, it seems plausible that this interaction could augment the uptake of cell-bound DNA. Differences in affinity for staphylococcal DNA might partially explain the differences in enhancing activities among sera and FN from various animal sources (Table 1) .
